This is a prospective, single-center, randomized, active controlled, clinical trail to assess the efficacy and safety of surgical closure of left atrial appendage (LAA) in patients undergoing coronary artery bypass graft.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
240
CABG according to indications in the current guidelines on myocardial revascularization including surgical closure of left atrial appendage
Beijing Anzhen Hospital
Beijing, China
RECRUITINGAll-cause death
Time frame: 3 year after discharge (These data is collected during follow-up visit at in-hospital)
Atrial fibrillation
Time frame: 3 year after discharge (These data is collected during follow-up visit at in-hospital)
Composite of ischemic stroke, thromboembolism and all death
Time frame: 3 year after discharge (These data is collected during follow-up visit at in-hospital)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.